TY - JOUR
T1 - Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol
T2 - Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3)
AU - Nury, Thomas
AU - Zarrouk, Amira
AU - Mackrill, John J
AU - Samadi, Mohammad
AU - Durand, Philippe
AU - Riedinger, Jean-Marc
AU - Doria, Margaux
AU - Vejux, Anne
AU - Limagne, Emeric
AU - Delmas, Dominique
AU - Prost, Michel
AU - Moreau, Thibault
AU - Hammami, Mohamed
AU - Delage-Mourroux, Régis
AU - O'Brien, Nora M
AU - Lizard, Gérard
N1 - Copyright © 2015 Elsevier Inc. All rights reserved.
PY - 2015/7
Y1 - 2015/7
N2 - In demyelinating or non-demyelinating neurodegenerative diseases, increased levels of 7-ketocholesterol (7KC), 7β-hydroxycholesterol (7β-OHC) and 24(S)-hydroxycholesterol (24S-OHC) can be observed in brain lesions. In 158N murine oligodendrocytes, 7KC triggers a complex mode of cell death defined as oxiapoptophagy, involving simultaneous oxidative stress, apoptosis and autophagy. In these cells, 7KC as well as 7β-OHC and 24S-OHC induce a decrease of cell proliferation evaluated by phase contrast microscopy, an alteration of mitochondrial activity quantified with the MTT test, an overproduction of reactive oxygen species revealed by staining with dihydroethidium and dihydrorhodamine 123, caspase-3 activation, PARP degradation, reduced expression of Bcl-2, and condensation and/or fragmentation of the nuclei which are typical criteria of oxidative stress and apoptosis. Moreover, 7KC, 7β-OHC and 24S-OHC promote conversion of microtubule-associated protein light chain 3 (LC3-I) to LC3-II which is a characteristic of autophagy. Consequently, 7β-OHC and 24S-OHC, similarly to 7KC, can be considered as potent inducers of oxiapoptophagy. Furthermore, the different cytotoxic effects associated with 7KC, 7β-OHC and 24S-OHC-induced oxiapoptophagy are attenuated by vitamin E (VitE, α-tocopherol) and DHA which enhances VitE protective effects. In 158N murine oligodendrocytes, our data support the concept that oxiapoptophagy, which can be inhibited by VitE and DHA, could be a particular mode of cell death elicited by cytotoxic oxysterols.
AB - In demyelinating or non-demyelinating neurodegenerative diseases, increased levels of 7-ketocholesterol (7KC), 7β-hydroxycholesterol (7β-OHC) and 24(S)-hydroxycholesterol (24S-OHC) can be observed in brain lesions. In 158N murine oligodendrocytes, 7KC triggers a complex mode of cell death defined as oxiapoptophagy, involving simultaneous oxidative stress, apoptosis and autophagy. In these cells, 7KC as well as 7β-OHC and 24S-OHC induce a decrease of cell proliferation evaluated by phase contrast microscopy, an alteration of mitochondrial activity quantified with the MTT test, an overproduction of reactive oxygen species revealed by staining with dihydroethidium and dihydrorhodamine 123, caspase-3 activation, PARP degradation, reduced expression of Bcl-2, and condensation and/or fragmentation of the nuclei which are typical criteria of oxidative stress and apoptosis. Moreover, 7KC, 7β-OHC and 24S-OHC promote conversion of microtubule-associated protein light chain 3 (LC3-I) to LC3-II which is a characteristic of autophagy. Consequently, 7β-OHC and 24S-OHC, similarly to 7KC, can be considered as potent inducers of oxiapoptophagy. Furthermore, the different cytotoxic effects associated with 7KC, 7β-OHC and 24S-OHC-induced oxiapoptophagy are attenuated by vitamin E (VitE, α-tocopherol) and DHA which enhances VitE protective effects. In 158N murine oligodendrocytes, our data support the concept that oxiapoptophagy, which can be inhibited by VitE and DHA, could be a particular mode of cell death elicited by cytotoxic oxysterols.
KW - Animals
KW - Anions
KW - Apoptosis/drug effects
KW - Autophagy/drug effects
KW - Biomarkers/metabolism
KW - Cell Proliferation/drug effects
KW - Docosahexaenoic Acids/pharmacology
KW - Hydrogen Peroxide/metabolism
KW - Hydroxycholesterols/pharmacology
KW - Ketocholesterols/pharmacology
KW - Mice
KW - Microscopy, Phase-Contrast
KW - Mitochondria/drug effects
KW - Oligodendroglia/cytology
KW - Oxidation-Reduction/drug effects
KW - Protective Agents/pharmacology
KW - Superoxides/metabolism
KW - alpha-Tocopherol/pharmacology
U2 - 10.1016/j.steroids.2015.02.003
DO - 10.1016/j.steroids.2015.02.003
M3 - Article
C2 - 25683890
SN - 0039-128X
VL - 99
SP - 194
EP - 203
JO - Steroids
JF - Steroids
IS - Pt B
ER -